FDA: 2 Generic Versions Of ADHD Drug ‘Concerta’ Not As Effective

November 15, 2014 12:51 AM

22 0

Two generic versions of the attention-deficit/hyperactivity disorder drug Concerta may not work as effectively as the brand-name product does, the U.S. Food and Drug Administration said Thursday.

The agency analyzed available data and conducted laboratory tests on the two generic versions of Concerta (methylphenidate hydrochloride extended-release tablets) made by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd.

Read more

To category page